Pembrolizumab
Drug timelines are a Plus or Pro feature.
1072 regulatory and trial events tracked for Pembrolizumab, covering 2016-01-14 to 2026-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]